Sigyn Therapeutics reduces authorized common shares to 100M via charter amendment

Sigyn Therapeutics, Inc.

Filed Certificate of Amendment decreasing authorized common stock to 100 million shares (par value $0.0001).
Authorized preferred stock unchanged at 10 million shares (par value $0.0001).
Amendment effective upon filing on December 30, 2024.
No other changes to the Amended and Restated Certificate of Incorporation.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Sigyn Therapeutics, Inc.: Amended authorized common stock to 100,000,000 shares (effective 2024-12-30).

Change: charter amendment
Effective: 2024-12-30

Exact text from the filing

On December 30, 2024, we filed a Certificate of Amendment to our Amended and Restated Certificate of Incorporation with the State of Delaware, which went effective immediately upon filing. The Certificate of Amendment decreased our authorized common stock to One Hundred Million (100,000,000) shares, par value $0.0001.

View on SEC.gov

Browse all governance changes →

Sigyn Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-001074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.